By Richard Hook2018-11-28T14:08:00
Joint venture partners Stanhope, Mitsui Fudosan and AIMCo have secured a landmark tenant for White City Place with global pharmaceutical giant Novartis having signed to make the west London campus its new UK headquarters.
Novartis will initially be taking 54,000 sq ft of space from March 2019, with the option to expand further to 65,000 sq ft come January 2020.
The JV partners signed Autolus to become the first major life sciences company to take space at White City Place in August this year and Novartis will also join fellow bio tech firm Synthace at the 1.9m sq ft business, innovation and life sciences district.
You must be logged in to continue
Register for free to finish this article
Registration includes the following benefits:
To access this article REGISTER NOW
Four articles not enough? SUBSCRIBE for unlimited access to over 100 weekly articles and our comprehensive archive. For as little as £5 per week.